-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
-
Gladstone Alternative Income Fund Announces Monthly Cash Distribution for November 2026
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
-
With Expansion into Naval Shipbuilding, Hanwha Philly Shipyard Names 25-Year Shipbuilding Veteran as President
-
ASGA's Attack on Menhaden Science Exposes Its Own Double Standard
-
Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month
-
Hop-on (OTCID: HPNN) Subsidiary Digitalage Completes Core Cre-ator Platform Build, Moves to Enterprise Technology Licensing
Luc Montagnier: HIV discoverer who ended a pariah
French researcher Luc Montagnier, who has died at 89, shared the Nobel medicine prize for his vital early discoveries on AIDS, but was later dismissed by the scientific community for his increasingly outlandish theories, notably on Covid-19.
Montagnier and Francoise Barre-Sinoussi shared the Nobel in 2008 for their work at the Pasteur Institute in Paris in isolating the human immunodeficiency virus (HIV).
Their achievement sped the way to HIV tests and antiretroviral drugs that keep the deadly pathogen at bay.
- Bitter rivalry -
AIDS -- acquired immune deficiency syndrome -- first came to public notice in 1981, when US doctors noted an unusual cluster of deaths among young gay men in California and New York.
Montagnier had a bitter rivalry with US scientist Robert Gallo in his ground-breaking work in identifying HIV at the virology department he created in Paris in 1972.
Both are co-credited with discovering that HIV causes AIDS, and their rival claims led for several years to a legal and even diplomatic dispute between France and the United States.
Montagnier's work started in January 1983, when tissue samples arrived at the Pasteur Institute from a patient with a disease that mysteriously wrecked the immune system.
He later recalled the "sense of isolation" as the team battled to make this vital connection.
"The results we had were very good but they were not accepted by the rest of the scientific community for at least another year, until Robert Gallo confirmed our results in the US," he said.
The Nobel jury made no mention of Gallo in its citation.
In 1986 Montagnier shared the Lasker Award -- the US equivalent of the Nobel -- with Gallo and Myron Essex.
In 2011, to mark 30 years since the appearance of AIDS, Montagnier warned of the spiralling costs of treating the 33 million then stricken with HIV.
"Treatment cuts transmission, that's clear, but it doesn't eradicate it, and we can't treat all the millions of people," he told AFP.
- Controversial ideas -
Montagnier was born on August 8, 1932 at Chabris in the Indre region of central France.
After heading Pasteur's AIDS department from 1991 to 1997, and then teaching at Queens College in New York, Montagnier gradually drifted to the scientific fringes, stirring controversy after controversy.
He repeatedly suggested that autism is caused by infection and set up much-criticised experiments to prove it, claiming antibiotics could cure the condition.
He stunned many of his peers when he talked of the purported ability of water to retain a memory of substances.
And he believed that anyone with a good immune system could fight off HIV with the right diet.
Montagnier supported theories that DNA left an electromagnetic trace in water that could be used to diagnose AIDS and Lyme's Disease, and championed the therapeutic qualities of fermented papaya for Parkinson's Disease.
- 'Slow scientific shipwreck' -
He repeatedly took up positions against vaccines, earning a stinging reprimand in 2017 from 106 members of the Academies of Sciences and Medicines.
The French daily Le Figaro described his journey from leading researcher to crank as a "slow scientific shipwreck".
During the Covid pandemic he stood out again, stating that the SARS-CoV-2 virus was laboratory-made and that vaccines were responsible for the appearance of variants.
These theories, rejected by virologists and epidemiologists, made him even more into a pariah among his peers, but a hero to French anti-vaxxers.
O.Johnson--AMWN